Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.58 |
| ▸ | GAA | P10253 | 8/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.58 |
| ▸ | GFER | P55789 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | CDC25B | P30305 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 5/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | THRB | P10828 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 3/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | PLEC | Q15149 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29475726 | 1.00 | KDM4E (0.58) | KDM4EGAAHSD17B10GFERMEN1 | |
| SCHEMBL7142180 | 0.86 | KDM4E (0.48) | KDM4EGAAHSD17B10GFERMEN1 | |
| SCHEMBL8013848 | 0.84 | GAA (0.52) | KDM4EGAAHSD17B10GFERMEN1 | |
| SCHEMBL7162401 | 0.83 | CES2 (0.52) | KDM4EGAAHSD17B10GFERMEN1 | |
| Hydrochloric Acid SCHEMBL8752684 | 0.83 | GAA (0.50) | KDM4EGAAHSD17B10GFERMEN1 | |
| SCHEMBL3078849 | 0.83 | PARP1 (0.50) | KDM4EGAAHSD17B10GFERMEN1 | |
| Ammonia Solution, Strong SCHEMBL8752682 | 0.83 | GAA (0.50) | KDM4EGAAHSD17B10GFERMEN1 | |
| SCHEMBL8752661 | 0.83 | MAPT (0.50) | KDM4EGAAHSD17B10GFERMEN1 | |
| SCHEMBL97816 | 0.83 | HDAC1 (0.63) | KDM4EGAAHSD17B10GFERMEN1 | |
| SCHEMBL29367661 | 0.83 | HDAC1 (0.63) | KDM4EGAAHSD17B10GFERMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 355 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117800914-B | Anti-SARS-CoV-2 virus armstrong mutant inhibitor | 中国人民解放军海军军医大学 | 2026-05-19 | — | — | CN | claimed |
| CN-119320592-B | High-weather-resistance self-cleaning nano silicon coating and preparation process thereof | 云南云岭涂料有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119320592-A | High-weather-resistance self-cleaning nano silicon coating and preparation process thereof | 云南云岭涂料有限公司 | 2025-01-17 | — | — | CN | claimed |
| CN-116606257-A | Preparation process of intermediate 7-chloro 8-quinolinic acid and synthesis process of quinclorac | 启农生物科技(北京)有限公司 | 2023-08-18 | — | — | CN | claimed |
| CN-115974791-A | Preparation process of intermediate I for synthesizing saflufenacil | 启农生物科技(北京)有限公司 | 2023-04-18 | — | — | CN | claimed |
| CN-104530107-B | A kind of synthetic method of 3-amino-4-fluorobenzoic boric acid | 大连联化化学有限公司 | 2016-08-24 | — | — | CN | claimed |
| CN-103626791-B | A kind of method of synthesizing 3-amino-4-fluorobenzoic boric acid | LIANHUA CHEMISTRY Co.,Ltd. DALIAN (CN) | 2016-04-06 | — | — | CN | claimed |
| CN-104530107-A | Synthetic method for 3-amino-4-fluorophenylboronic acid | LIANHUA CHEMISTRY CO LTD DALIAN | 2015-04-22 | — | — | CN | claimed |
| CN-103626791-A | Method for synthesizing 3-amino-4-fluorophenylboronic acid | LIANHUA CHEMISTRY CO LTD DALIAN | 2014-03-12 | — | — | CN | claimed |
| US-20260144743-A1 | COMPOUNDS | TMEM16A LIMITED (GB) | 2026-05-28 | — | — | US | disclosed |
| CN-117800914-B | Anti-SARS-CoV-2 virus armstrong mutant inhibitor | 中国人民解放军海军军医大学 | 2026-05-19 | — | — | CN | disclosed |
| EP-4166557-B1 | INTERMEDIATES OF N-(3-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PHENYL)BENZAMIDE DERIVATIVES | NOVARTIS AG (CH) | 2026-05-06 | — | — | EP | disclosed |
| US-12569566-B2 | Compositions containing, methods and uses of antibody-TLR agonist conjugates | AMBRX, INC. (US) | 2026-03-10 | — | — | US | disclosed |
| EP-4699655-A2 | COMPOUNDS | TMEM16A LIMITED (GB) | 2026-02-25 | — | — | EP | disclosed |
| EP-0356080-B1 | Anionic dye | ZENECA LTD (GB) | 1994-06-08 | — | — | EP | disclosed |
| US-5262527-A | Disazo dyes suitable for use in ink jet printing | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-11-16 | — | — | US | disclosed |
| US-4929272-A | N-phenyl-maleimides and N-phenyl-succinimides and their use in a herbicidal and/or plant growth regulating action | CIBA-GEIGY CORPORATION (US) | 1990-05-29 | — | — | US | disclosed |
| US-4804400-A | PRE- AND POSTEMERGENCE; GRAINS | CIBA-GEIGY CORPORATION (US) | 1989-02-14 | — | — | US | disclosed |
| EP-0260228-A2 | N-phenyl-malein imides and N-phenyl-succinimides with a herbicidal and a plant growth regulation activity | CIBA-GEIGY AG (CH) | 1988-03-16 | — | — | EP | disclosed |
| US-4065448-A | Tertiary alkyl substituted disazo pigments | CIBA-GEIGY AG (CH) | 1977-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260144743-A1 | COMPOUNDS | CACNA1E, TMEM109, CACNA1C | KDM4E 3794/4885GAA 1568/4885HSD17B10 868/4885 |
| US-12569566-B2 | Compositions containing, methods and uses of antibody-TLR agonist conjugates | TLR3, TLR2, TLR1 | KDM4E 125/4885GAA 2983/4885HSD17B10 1843/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.